¹Ù·Î°¡±â ¸Þ´º

¹Ù·Î°¡±â ¸Þ´º º»¹®³»¿ë ¹Ù·Î°¡±â ¸ÞÀθ޴º ¹Ù·Î°¡±â

ÁÖ¿ä¾È³»

HOME »çÀÌÆ®¸Ê

FONT SIZE

ÆùƮũ±â Å°¿ò 100% 110% 120% 130% 140% ÆùƮũ±â ÁÙÀÓ
¸Þ´ºº¸±â
 
Á¦¸ñ
3/28 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
ÀÛ¼ºÀÏ
2020-03-25
Á¶È¸¼ö
287


¾È³çÇϼ¼¿ä À̹øÁÖ ¹ßÇ¥ÀÚ ³ª·¡ÀÔ´Ï´Ù.
Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÒ ³í¹®Àº
¿ÃÇØ 1¿ù frontiers in microbiology¿¡ °ÔÀçµÈ

"CD163ΔSRCR5 MARC-145 cells resist PRRSV-2 infection via inhibiting virus uncoating, which require the interaction of CD163 with calpain1"À̶ó´Â Á¦¸ñÀÇ ³í¹®À¸·Î,
±âÁ¸¿¡ CD163ÀÌ PRRSVÀÇ receptorÀÎ °ÍÀº Àß ¾Ë·ÁÁ® ÀÖÁö¸¸, CD163À» Marc-145cell¿¡¼­ CRISPR/Cas9 ±â¼úÀ» ÅëÇØ deletion½ÃÅ´À¸·Î½á CD163À» ÅëÇÑ virusÀÇ uncoatingÀÌ calpain 1(calcium-dependent neutral protease 1)À̶ó´Â enzyme°úÀÇ interactionÀ» ÅëÇØ ÀÌ·ç¾îÁø´Ù´Â »ç½ÇÀ» »õ·Ó°Ô ¹àÈù ³í¹®ÀÔ´Ï´Ù.

Á¦ ¿¬±¸¿¡ ÀÖ¾î Âü°íÇÒ¸¸ÇÑ ³»¿ëÀ̶ó ¼Ò°³½ÃÄѵ帮°íÀÚ ¼±Á¤ÇϰԵǾú½À´Ï´Ù.
¿­½ÉÈ÷ ÁغñÇÏ¿© Åä¿äÀÏ¿¡ ºË°Ú½À´Ï´Ù.

³í¹® ¸µÅ©: https://www.frontiersin.org/articles/10.3389/fmicb.2019.03115/full

÷ºÎÆÄÀÏ:
÷ºÎÆÄÀÏÀÌ ¾ø½À´Ï´Ù.
´ÙÀ½±Û
3/28ÀÏ ¹ßÇ¥³í¹®ÀÔ´Ï´Ù.
/ ±èö±Õ
¾È³çÇϼ¼¿ä ö±ÕÀÔ´Ï´Ù. À̹øÁÖ Åä¿äÀÏ ¼¼¹Ì³ª¿¡¼­ ¹ßÇ¥µå¸± ³í¹®Àº 2016³â nature immunology¿¡¼­ ¹ßÇ¥ µÇ¾ú´ø, "The lectin Siglec-G inhibits dendritic cell cross-presentation by impairing MHC class I-peptide complex formation." ÀÔ´Ï´Ù. cross-presentationÀ» ¿¬±¸ÇÏ´Â ÁÖ¿ä ¿¬±¸ÆÀµéÀÇ ¿¬±¸..
ÀÌÀü±Û
3/21 ¹ßÇ¥³í¹®ÀÔ´Ï´Ù
/ ±¸¹ÎÁ¤
¾È³çÇϼ¼¿ä, ¹ÎÁ¤ÀÔ´Ï´Ù. https://www.sciencedirect.com/science/article/pii/S1074761320300297?via%3Dihub#undfig1 Á¦°¡ À̹øÁÖ ¹ßÇ¥ÇÒ ³í¹®Àº ¿ÃÇØ Immunity¿¡ °ÔÀçµÈ °ÍÀ¸·Î, ´Ù¾çÇÑ Áúº´ ¹× ¿°Áõ »óȲ¿¡ °ü¿©ÇÏ´Â »çÀÌÅäÄ«ÀÎ Áß ÇϳªÀÎ IL-17A¿¡ ´ëÇÑ ³í¹®ÀÔ´Ï´Ù. ƯÈ÷ ÀÚ°¡¸é¿ªÁúȯ¿¡..